259 related articles for article (PubMed ID: 21224835)
21. CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa.
Wu WH; Tsai YT; Huang IW; Cheng CH; Hsu CW; Cui X; Ryu J; Quinn PMJ; Caruso SM; Lin CS; Tsang SH
Mol Ther; 2022 Apr; 30(4):1407-1420. PubMed ID: 35150888
[TBL] [Abstract][Full Text] [Related]
22. Challenging Safety and Efficacy of Retinal Gene Therapies by Retinogenesis.
Marrocco E; Maritato R; Botta S; Esposito M; Surace EM
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071252
[TBL] [Abstract][Full Text] [Related]
23. Progress in Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa.
Sudharsan R; Beltran WA
Adv Exp Med Biol; 2019; 1185():113-118. PubMed ID: 31884598
[TBL] [Abstract][Full Text] [Related]
24. Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approach.
Kiang AS; Palfi A; Ader M; Kenna PF; Millington-Ward S; Clark G; Kennan A; O'reilly M; Tam LC; Aherne A; McNally N; Humphries P; Farrar GJ
Mol Ther; 2005 Sep; 12(3):555-61. PubMed ID: 15967729
[TBL] [Abstract][Full Text] [Related]
25. Gene therapy provides long-term visual function in a pre-clinical model of retinitis pigmentosa.
Wert KJ; Davis RJ; Sancho-Pelluz J; Nishina PM; Tsang SH
Hum Mol Genet; 2013 Feb; 22(3):558-67. PubMed ID: 23108158
[TBL] [Abstract][Full Text] [Related]
26. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa.
Lewin AS; Drenser KA; Hauswirth WW; Nishikawa S; Yasumura D; Flannery JG; LaVail MM
Nat Med; 1998 Aug; 4(8):967-71. PubMed ID: 9701253
[TBL] [Abstract][Full Text] [Related]
27. Long-term rescue of cone photoreceptor degeneration in retinitis pigmentosa 2 (RP2)-knockout mice by gene replacement therapy.
Mookherjee S; Hiriyanna S; Kaneshiro K; Li L; Li Y; Li W; Qian H; Li T; Khanna H; Colosi P; Swaroop A; Wu Z
Hum Mol Genet; 2015 Nov; 24(22):6446-58. PubMed ID: 26358772
[TBL] [Abstract][Full Text] [Related]
28. The nature of dominant mutations of rhodopsin and implications for gene therapy.
Wilson JH; Wensel TG
Mol Neurobiol; 2003 Oct; 28(2):149-58. PubMed ID: 14576453
[TBL] [Abstract][Full Text] [Related]
29. Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa.
Dryja TP; McGee TL; Hahn LB; Cowley GS; Olsson JE; Reichel E; Sandberg MA; Berson EL
N Engl J Med; 1990 Nov; 323(19):1302-7. PubMed ID: 2215617
[TBL] [Abstract][Full Text] [Related]
30. Rhodopsin gene codon 106 mutation (Gly-to-Arg) in a Japanese family with autosomal dominant retinitis pigmentosa.
Budu ; Matsumoto M; Hayasaka S; Yamada T; Hayasaka Y
Jpn J Ophthalmol; 2000; 44(6):610-4. PubMed ID: 11094174
[TBL] [Abstract][Full Text] [Related]
31. Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa.
Olsson JE; Gordon JW; Pawlyk BS; Roof D; Hayes A; Molday RS; Mukai S; Cowley GS; Berson EL; Dryja TP
Neuron; 1992 Nov; 9(5):815-30. PubMed ID: 1418997
[TBL] [Abstract][Full Text] [Related]
32. Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype.
Han Z; Banworth MJ; Makkia R; Conley SM; Al-Ubaidi MR; Cooper MJ; Naash MI
FASEB J; 2015 Jun; 29(6):2535-44. PubMed ID: 25713057
[TBL] [Abstract][Full Text] [Related]
33. Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa.
McGee Sanftner LH; Abel H; Hauswirth WW; Flannery JG
Mol Ther; 2001 Dec; 4(6):622-9. PubMed ID: 11735347
[TBL] [Abstract][Full Text] [Related]
34. Limited ATF4 Expression in Degenerating Retinas with Ongoing ER Stress Promotes Photoreceptor Survival in a Mouse Model of Autosomal Dominant Retinitis Pigmentosa.
Bhootada Y; Kotla P; Zolotukhin S; Gorbatyuk O; Bebok Z; Athar M; Gorbatyuk M
PLoS One; 2016; 11(5):e0154779. PubMed ID: 27144303
[TBL] [Abstract][Full Text] [Related]
35. Adeno-associated virus-mediated rhodopsin replacement provides therapeutic benefit in mice with a targeted disruption of the rhodopsin gene.
Palfi A; Millington-Ward S; Chadderton N; O'Reilly M; Goldmann T; Humphries MM; Li T; Wolfrum U; Humphries P; Kenna PF; Farrar GJ
Hum Gene Ther; 2010 Mar; 21(3):311-23. PubMed ID: 19824806
[TBL] [Abstract][Full Text] [Related]
36. Gene-based therapies for dominantly inherited retinopathies.
Farrar GJ; Millington-Ward S; Chadderton N; Humphries P; Kenna PF
Gene Ther; 2012 Feb; 19(2):137-44. PubMed ID: 22089493
[TBL] [Abstract][Full Text] [Related]
37. Ocular findings in patients with autosomal dominant retinitis pigmentosa and a rhodopsin gene defect (Pro-23-His).
Berson EL; Rosner B; Sandberg MA; Dryja TP
Arch Ophthalmol; 1991 Jan; 109(1):92-101. PubMed ID: 1987956
[TBL] [Abstract][Full Text] [Related]
38. Autosomal dominant sectoral retinitis pigmentosa. Two families with transversion mutation in codon 23 of rhodopsin.
Heckenlively JR; Rodriguez JA; Daiger SP
Arch Ophthalmol; 1991 Jan; 109(1):84-91. PubMed ID: 1987955
[TBL] [Abstract][Full Text] [Related]
39. A new codon 15 rhodopsin gene mutation in autosomal dominant retinitis pigmentosa is associated with sectorial disease.
Sullivan LJ; Makris GS; Dickinson P; Mulhall LE; Forrest S; Cotton RG; Loughnan MS
Arch Ophthalmol; 1993 Nov; 111(11):1512-7. PubMed ID: 8240107
[TBL] [Abstract][Full Text] [Related]
40. Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized
Dufour VL; Cideciyan AV; Ye GJ; Song C; Timmers A; Habecker PL; Pan W; Weinstein NM; Swider M; Durham AC; Ying GS; Robinson PM; Jacobson SG; Knop DR; Chulay JD; Shearman MS; Aguirre GD; Beltran WA
Hum Gene Ther; 2020 Feb; 31(3-4):253-267. PubMed ID: 31910043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
